(PDF) EZH2 contributes to 5-FU resistance in gastric sorted by
relevance

Admin08.08.2021

(PDF) EZH2 contributes to 5-FU resistance in gastric

1605
Admin04.08.2021

(PDF) EZH2 contributes to 5-FU resistance in gastric

1103
Admin31.07.2021

(PDF) EZH2 contributes to 5-FU resistance in gastric

4502
Admin05.09.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

6803
Admin22.07.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

3209
Admin09.09.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

7806
Admin07.10.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

2707
Admin23.09.2021

(PDF) EZH2 Contributes To Cisplatin Resistance In Breast

3703
Admin02.08.2021

(PDF) EZH2 contributes to 5-FU resistance in gastric

6005
Admin19.07.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

2502
Admin06.09.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

1900
Admin01.10.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

5502
Admin09.08.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

8603
Admin01.08.2021

(PDF) lncRNA UCA1 Contributes to 5-Fluorouracil Resistance

7003
Admin19.08.2021

(PDF) Overexpression of EZH2 contributes to acquired

2802
Admin07.10.2021

Dysregulation of EZH2/miR-138 axis contributes to drug

Admin19.08.2021

(PDF) TSPAN9 suppresses the chemosensitivity of gastric

9304
Admin05.08.2021

(PDF) GRP78 confers the resistance to 5-FU by activating

6802
Admin24.09.2021

(PDF) Overexpression of cIAP2 contributes to 5-FU

Admin15.07.2021

(PDF) lncRNA UCA1 Contributes to 5-Fluorouracil Resistance

4400
Admin14.09.2021

[Full text] EZH2 contributes to 5-FU resistance in gastric

9904